A Repeat Dose Study With GSK1018921 to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics in Healthy Volunteers and Patients With Schizophrenia and to Evaluate Its Effect on PK of Midazolam.
Clinical trial NCT00929370 · TERMINATED
Trial details
- NCT number
- NCT00929370
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2008-10-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.